Year |
Citation |
Score |
2025 |
Mu W, Tomer S, Harding J, Kedia N, Rezek V, Cook E, Patankar V, Carrillo MA, Martin H, Ng HL, Wang L, Marsden MD, Kitchen SD, Zhen A. Rapamycin Enhances CAR-T Control of HIV Replication and Reservoir Elimination in vivo. The Journal of Clinical Investigation. PMID 39932788 DOI: 10.1172/JCI185489 |
0.464 |
|
2024 |
Guo Q, Parikh K, Zhang J, Brinkley A, Chen G, Jakramonpreeya N, Zhen A, An DS. Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection. Biorxiv : the Preprint Server For Biology. PMID 39605384 DOI: 10.1101/2024.11.13.623476 |
0.519 |
|
2024 |
Carrillo MA, Zhen A, Mu W, Rezek V, Martin H, Peterson CW, Kiem HP, Kitchen SG. Stem cell-derived CAR T cells show greater persistence, trafficking, and plasma viral control compared to ex vivo transduced CAR T cells in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 38414243 DOI: 10.1016/j.ymthe.2024.02.026 |
0.43 |
|
2024 |
Mu W, Patankar V, Kitchen S, Zhen A. Examining Chronic Inflammation, Immune Metabolism, and T Cell Dysfunction in HIV Infection. Viruses. 16. PMID 38399994 DOI: 10.3390/v16020219 |
0.478 |
|
2023 |
Mu W, Martin H, Zhen A. Targeting autophagy to treat HIV immune dysfunction. Autophagy Reports. 2. PMID 38435700 DOI: 10.1080/27694127.2023.2254615 |
0.49 |
|
2022 |
Mu W, Rezek V, Martin H, Carrillo MA, Tomer S, Hamid P, Lizarraga MA, Tibbe TD, Yang OO, Jamieson BD, Kitchen SG, Zhen A. Autophagy inducer rapamycin treatment reduces IFN-I-mediated Inflammation and improves anti-HIV-1 T cell response in vivo. Jci Insight. 7. PMID 36509289 DOI: 10.1172/jci.insight.159136 |
0.48 |
|
2022 |
Mu W, Zhen A, Carrillo MA, Rezek V, Martin H, Lizarraga M, Kitchen S. Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice. Journal of Visualized Experiments : Jove. PMID 36282697 DOI: 10.3791/63696 |
0.494 |
|
2022 |
Tomer S, Mu W, Suryawanshi G, Ng H, Wang L, Wennerberg W, Rezek V, Martin H, Chen I, Kitchen S, Zhen A. Cannabidiol modulates expression of type I IFN response genes and HIV infection in macrophages. Frontiers in Immunology. 13: 926696. PMID 36248834 DOI: 10.3389/fimmu.2022.926696 |
0.465 |
|
2021 |
Zhen A, Carrillo MA, Mu W, Rezek V, Martin H, Hamid P, Chen ISY, Yang OO, Zack JA, Kitchen SG. Robust CAR-T memory formation and function via hematopoietic stem cell delivery. Plos Pathogens. 17: e1009404. PMID 33793675 DOI: 10.1371/journal.ppat.1009404 |
0.479 |
|
2021 |
Barber-Axthelm IM, Barber-Axthelm V, Sze KY, Zhen A, Suryawanshi GW, Chen IS, Zack JA, Kitchen SG, Kiem HP, Peterson CW. Stem cell-derived CAR T cells traffic to HIV reservoirs in macaques. Jci Insight. 6. PMID 33427210 DOI: 10.1172/jci.insight.141502 |
0.481 |
|
2020 |
Lim RM, Rong L, Zhen A, Xie J. A Universal CAR-NK Cell Targeting Various Epitopes of HIV-1 gp160. Acs Chemical Biology. PMID 32667183 DOI: 10.1021/Acschembio.0C00537 |
0.446 |
|
2019 |
Bochnakian A, Zhen A, Zisoulis DG, Idica A, KewalRamani VN, Neel N, Daugaard I, Hamdorf M, Kitchen S, Lee K, Pedersen IM. Interferon-inducible miR-128 modulates HIV-1 replication by targeting TNPO3 mRNA. Journal of Virology. PMID 31341054 DOI: 10.1128/Jvi.00364-19 |
0.464 |
|
2019 |
Norton TD, Zhen A, Tada T, Kim J, Kitchen S, Landau NR. Lentiviral Vector-Based Dendritic Cell Vaccine Suppresses HIV Replication in Humanized Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30962161 DOI: 10.1016/J.Ymthe.2019.03.008 |
0.517 |
|
2018 |
Carrillo MA, Zhen A, Kitchen SG. The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer. Frontiers in Immunology. 9: 746. PMID 29755454 DOI: 10.3389/Fimmu.2018.00746 |
0.486 |
|
2018 |
Zhen A, Peterson CW, Carrillo MA, Reddy SS, Youn CS, Lam BB, Chang NY, Martin HA, Rick JW, Kim J, Neel NC, Rezek VK, Kamata M, Chen ISY, Zack JA, et al. Correction: Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS. Plos Pathogens. 14: e1006891. PMID 29529058 DOI: 10.1371/journal.ppat.1006891 |
0.361 |
|
2017 |
Zhen A, Peterson CW, Carrillo MA, Reddy SS, Youn CS, Lam BB, Chang NY, Martin HA, Rick JW, Kim J, Neel NC, Rezek VK, Kamata M, Chen ISY, Zack JA, et al. Long-term persistence and function of hematopoietic stem cell-derived chimeric antigen receptor T cells in a nonhuman primate model of HIV/AIDS. Plos Pathogens. 13: e1006753. PMID 29284044 DOI: 10.1371/Journal.Ppat.1006753 |
0.447 |
|
2017 |
Carrillo MA, Zhen A, Zack JA, Kitchen SG. New approaches for the enhancement of chimeric antigen receptors for the treatment of HIV. Translational Research : the Journal of Laboratory and Clinical Medicine. PMID 28755872 DOI: 10.1016/J.Trsl.2017.07.002 |
0.554 |
|
2017 |
Zhen A, Carrillo MA, Kitchen SG. Chimeric antigen receptor engineered stem cells: a novel HIV therapy. Immunotherapy. 9: 401-410. PMID 28357916 DOI: 10.2217/Imt-2016-0121 |
0.558 |
|
2016 |
Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, Carrillo M, Martin H, Kasparian S, Syed P, Rice N, Brooks DG, Kitchen SG. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. The Journal of Clinical Investigation. PMID 27941243 DOI: 10.1172/Jci89488 |
0.557 |
|
2016 |
Zhen A, Rezek V, Youn C, Rick J, Lam B, Chang N, Zack J, Kamata M, Kitchen S. Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model. Journal of Visualized Experiments : Jove. PMID 27404517 DOI: 10.3791/54048 |
0.5 |
|
2016 |
Cunningham CR, Champhekar A, Tullius MV, Dillon BJ, Zhen A, de la Fuente JR, Herskovitz J, Elsaesser H, Snell LM, Wilson EB, de la Torre JC, Kitchen SG, Horwitz MA, Bensinger SJ, Smale ST, et al. Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral Persistence. Plos Pathogens. 12: e1005356. PMID 26808628 DOI: 10.1371/Journal.Ppat.1005356 |
0.365 |
|
2015 |
Zhen A, Kamata M, Rezek V, Rick J, Levin B, Kasparian S, Chen IS, Yang OO, Zack JA, Kitchen SG. HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 23: 1358-67. PMID 26050990 DOI: 10.1038/Mt.2015.102 |
0.578 |
|
2015 |
Zhen A, Kamata M, Rezek V, Rick J, Levin B, Kasparian S, Chen ISY, Yang OO, Zack JA, Kitchen SG. HIV-specific Immunity Derived From Chimeric Antigen Receptor-engineered Stem Cells Molecular Therapy. DOI: 10.1038/mt.2015.102 |
0.394 |
|
2014 |
Zhen A, Krutzik SR, Levin BR, Kasparian S, Zack JA, Kitchen SG. CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection. Journal of Virology. 88: 9934-46. PMID 24942581 DOI: 10.1128/Jvi.00616-14 |
0.368 |
|
2014 |
Zhen A, Kitchen S. Stem-cell-based gene therapy for HIV infection. Viruses. 6: 1-12. PMID 24368413 DOI: 10.3390/V6010001 |
0.552 |
|
2012 |
Zhen A, Du J, Zhou X, Xiong Y, Yu XF. Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities. Plos One. 7: e38771. PMID 22859935 DOI: 10.1371/Journal.Pone.0038771 |
0.484 |
|
2010 |
Zhen A, Wang T, Zhao K, Xiong Y, Yu XF. A single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivity. Journal of Virology. 84: 1902-11. PMID 19939923 DOI: 10.1128/Jvi.01509-09 |
0.559 |
|
Show low-probability matches. |